Rockwell Medical, INC Form 4 insider transactions

Timothy Chole, Senior Vice President and Chief Commercial Officer of Rockwell Medical, Inc., sold 2,868 shares of common stock for $0.82 per share as part of a pre-established Rule 10b5-1 trading plan.

Rockwell Medical's SVP and CFO, Jesse Neri, sold 886 shares of common stock at a weighted average price of $0.82 per share on July 1, 2025, as part of a pre-established Rule 10b5-1 trading plan.

Rockwell Medical, Inc.'s President and CEO, Mark Strobeck, sold 6,926 shares of common stock at a weighted average price of $0.82 per share, executed under a Rule 10b5-1 trading plan.

Director Joan Lau acquired 50,000 shares of Rockwell Medical common stock on May 20, 2025, and disposed of 113,111 shares.

Director John G. Cooper acquired 50,000 shares of Rockwell Medical common stock on May 20, 2025, through restricted stock units.

Director Allen Nissenson acquired 50,000 shares of Rockwell Medical common stock on May 20, 2025, as part of a restricted stock unit grant.

Director Mark Ravich acquired 50,000 shares of Rockwell Medical common stock on May 20, 2025, as part of a restricted stock unit vesting.

Robert S. Radie, a director at Rockwell Medical, acquired 50,000 shares of common stock on May 20, 2025, as part of a restricted stock unit grant.

Director Andrea Heslin Smiley acquired 50,000 shares of Rockwell Medical common stock on May 20, 2025, through the vesting of restricted stock units.

Timothy Chole, SVP, Chief Commercial Officer of Rockwell Medical, reports the acquisition of 85,000 shares of common stock and disposal of shares, along with the acquisition of stock options.

Jesse Neri, SVP, Finance and CFO of Rockwell Medical, reports acquiring and disposing of common stock and acquiring stock options.

Megan Timmins, EVP, CLO and Secretary of Rockwell Medical, reports acquisition of common stock and stock options.

Rockwell Medical's CEO, Mark Strobeck, acquired 220,000 shares of common stock and 308,000 stock options on May 20, 2025.

The Irrevocable Larson Family Investment Trust has increased its holdings in Rockwell Medical, Inc. (RMTI) through a series of open market purchases.

Mark Strobeck, President and CEO of Rockwell Medical, sold 6,926 shares of common stock at an average price of $1.08 on April 1, 2025, under a pre-arranged trading plan.

Jesse Neri, SVP, Finance and CFO of Rockwell Medical, sold 886 shares of common stock on April 1, 2025, according to a Form 4 filing.

Timothy Chole, SVP, Chief Commercial Officer of Rockwell Medical, sold 2,868 shares of common stock on April 1, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Timothy Chole, SVP and Chief Commercial Officer of Rockwell Medical, disposed of shares to cover tax withholding obligations related to vesting restricted stock units.

Jesse Neri, SVP, Finance and CFO of Rockwell Medical, reports disposing of 2,444 common stock shares to cover tax obligations related to vesting restricted stock units.

Megan Timmins, EVP, CLO and Secretary of Rockwell Medical, reports disposing of common stock to cover tax withholding obligations related to vesting restricted stock units.

Mark Strobeck, CEO of Rockwell Medical, disposed of shares to cover tax withholding obligations related to vesting restricted stock units.

Timothy Chole, SVP, Chief Commercial Officer of Rockwell Medical, sold 1,001 shares of common stock at an average price of $2.05 on January 2, 2025, under a pre-arranged 10b5-1 trading plan.

Rockwell Medical's CEO, Mark Strobeck, sold 2,163 shares of common stock at $2.055 per share on January 2, 2025, under a pre-arranged 10b5-1 trading plan.

Mark H. Ravich, a director at Rockwell Medical, sold a total of 29,991 shares of common stock in recent transactions.

Timothy Chole, SVP, Chief Commercial Officer of Rockwell Medical, reports the sale of 1,001 shares of common stock on October 1, 2024, under a pre-arranged trading plan.

Mark Strobeck, CEO of Rockwell Medical, sold 2,163 shares of common stock at an average price of $3.6852 on October 1, 2024, under a pre-arranged trading plan.

Robert S. Radie, a director at Rockwell Medical, Inc., acquired 36,111 shares of common stock in the form of restricted stock units on May 21, 2024.

Director Mark Ravich reports acquisition of restricted stock units and adjustments to beneficial ownership reflecting a reverse stock split.

Director Joan Lau reports acquiring and disposing of Rockwell Medical common stock on May 21, 2024, according to a Form 4 filing.

Director John G. Cooper acquired 36,111 shares of Rockwell Medical, Inc. common stock through restricted stock units, according to a recent SEC Form 4 filing.